GARLAND J. SCOTT sold 13K shares of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $606.7K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/5/2026ACC: 0001533228-26-000009
Director
Since Feb 2026
-13K
Net shares
Net seller
$606.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
13K acquired · 26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+13K
Price / share
$15.47
Trade value
$201.11K
% of position
New position
10/1/2026
0.00→13K
Common Stock
Direct
Shares
−13K
Price / share
$46.67
Trade value
$606.72K
% of position
New position
10/1/2026
13K→0.00
Total
Net shares
+0.00
Net value
-$405.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2026 | M · Option Exercise | +13K | $15.47 | $201.11K | New position | 0.00 | 13K |
| Common Stock Direct | 10/1/2026 | S · Sale | −13K | $46.67 | $606.72K | New position | 13K | 0.00 |
| Total | +0.00 | -$405.61K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
13K shares
Shares
−13K
Strike price
15.47
Held after
46.37K
Exercisable
—
10/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock13K shares | 10/1/2026 | M · Option Exercise | −13K | 15.47 | — | 46.37K |